Effects of lawsone methyl ether mouthwash on oral Candida in HIV-infected subjects and subjects with denture stomatitis

Journal of Oral Pathology and Medicine

Volumn 42, Issue 9, 2013, Pages 698-704

  Nittayananta, Wipawee ^a   Pangsomboon, Kanokporn ^a   Panichayupakaranant, Pharkphoom ^a   Chanowanna, Nilnara ^b   Chelae, Sureerat ^a   Vuddhakul, Varaporn ^a   Sukhumungoon, Pharanai ^a   Pruphetkaew, Nannapat ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b Dental Division   (Thailand)

Author keywords

Antifungal activity; Antifungal drug resistance; Candida; Chlorhexidine; Genotyping; HIV; Lawsone methyl ether; Mouthwash

Indexed keywords

AMPHOTERICIN B; CHLORHEXIDINE; DIMETHYL ETHER; LAWSONE; MICONAZOLE; MOUTHWASH; NYSTATIN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DENTURE; DRUG EFFECT; DRUG HYPERSENSITIVITY; EDUCATION; FUNGAL GENE; FUNGUS CULTURE; GENDER; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCOME; INVERTED REPEAT; MARRIAGE; MOUTH HYGIENE; PATIENT SATISFACTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING HABIT; STOMATITIS; THRUSH; VISUAL ANALOG SCALE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL DRUG RESISTANCE; CANDIDA; CHLORHEXIDINE; GENOTYPING; HIV; LAWSONE METHYL ETHER; MOUTHWASH;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS, ORAL; CHLORHEXIDINE; DRUG RESISTANCE, FUNGAL; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; MOUTHWASHES; NAPHTHOQUINONES; PATIENT SATISFACTION; SMELL; STOMATITIS, DENTURE; TASTE;

EID: 84885908037     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12060     Document Type: Article

References (35)

1. Feigal DW, Katz MH, Greenspan D, et al. The prevalence of oral lesions in HIV infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991; 5: 519-25.
2. Greenspan JS, Barr CE, Sciubba JJ, Winkler JR. Oral manifestations of HIV infection. Definitions, diagnostic criteria, and principles of therapy. The U.S.A. Oral AIDS Collaborative Group. Oral Surg Oral Med Oral Pathol 1992; 73: 142-4.
3. Glick M, Muzyka BC, Lurie D, et al. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994; 77: 344-9.
4. Nittayananta W, Chungpanich S. Oral lesions in a group of Thai people with AIDS. Oral Dis 1997; 3: (Suppl. 1): S41-5.
5. Pereira-Cenci T, Del Bel Cury AA, Crielaard W, Ten Cate JM. Development of Candida-associated denture stomatitis: new insights. J Appl Oral Sci 2008; 16: 86-94.
6. Epstein JB, Vickars L, Spinelli J, Reece D. Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1992; 72: 291-5.
7. Greenspan D, Greenspan JS. Management of the oral lesions of HIV infection. J Am Dent Assoc 1991; 122: 26-32.
8. Langslet A, Olsen I, Lie SO, Lokken P. Chlorhexidine treatment of oral candidiasis in seriously disease children. Acta Paediatr Scand 1974; 63: 806-11.
9. Nittayananta W, DeRouen TA, Arirachakaran P, et al. A randomized clinical trial of chlorhexidine in the maintenance of oral candidiasis-free period in HIV infection. Oral Dis 2008; 14: 665-70.
10. Triphathi RD, Srivastava HS, Dixit SN. A fungitoxic principle from leaves of Lawsonia inermis Lam. Experientia 1978; 34: 51-2.
11. Rodriguez S, Wolfender JL, Hakizamungu E, Hostettmann K. An antifungal naphthoquinone, xanthones and secoiridoids from Swertia calycina. Planta Med 1995; 61: 362-4.
12. Yang X, Summerhurst DK, Koval SF, Ficker C, Smith ML, Bernards MA. Isolation of an antimicrobial compound from Impatiens balsamina L. using bioassay-guided fractionation. Phytother Res 2001; 15: 676-80.
13. Little JE, Sproston TJ, Foote MW. Isolation and antifungal action of naturally occurring 2-methoxy-1, 4-naphthoquinone. J Biol Chem 1948; 174: 335-42.
14. Sakunphueak A, Panichayupakaranant P. Comparison of antimicrobial activities of naphthoquinone from Impatiens balsamina. Nat Prod Res 2012; 26: 1119-24.
15. Sritrairat N, Nukul N, Inthasame P, et al. Antifungal activity of lawsone methyl ether in comparison with chlorhexidine. J Oral Pathol Med 2011; 40: 90-6.
16. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. Classification and Diagnostic Criteria for Oral Lesions in HIV Infection. J Oral Pathol Med 1993; 22: 289-91.
17. Samaranayake LP, MacFarlane TW, Lamey PJ, Ferguson MM. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol 1986; 15: 386-8.
18. Manfredi M, McCullough MJ, Polonelli L, et al. In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. Oral Microbiol Immunol 2006; 21: 177-82.
19. Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA. PCR fingerprinting of Candida albicans associated with chronic hyperplastic candidosis and other oral conditions. J Clin Microbiol 2011; 39: 4066-75.
20. Kasai M, Filioti J, Tsivitanidou M, Sofianou D, Kremenopoulos G, Walsh TJ. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 2003; 39: 735-41.
21. Diz Dios P, Ocampo A, Miralles C, Otero I, Iglesias I, Rayo N. Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 437-41.
22. Cauda R, Tacconelli E, Tumbarello M, et al. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. J Acquir Immune Defic Syndr 1999; 21: 20-5.
23. Munro CA, Hube B. Anti-fungal therapy at the HAART of viral therapy. Trends Microbiol 2002; 10: 173-7.
24. Panichayupakaranant P, Reanmongkol W. Evaluation of chemical stability and skin irritation of lawsone methyl ether in oral base. Pharm Biol 2002; 40: 429-32.
25. Salem AM, Adams D, Newman HN, et al. Antimicrobial properties of 2 aliphatic amine and chlorhexidine in vitro and in saliva. J Clin Periodontol 1987; 14: 44-7.
26. Bobichon H, Bouchet P. Action of chlorhexidine on budding Candida albicans: scanning and transmission electron microscope study. Mycopathologia 1987; 100: 27-35.
27. Elferink JG, Booij HL. Interaction of chlorhexidine with yeast cells. Biochem Pharmacol 1974; 23: 1413-9.
28. Hjeljord LG, Rolla G, Bonesvoll P. Chlorhexidine-protein interactions. J Periodontal Res Suppl 1973; 12: 11-6.
29. Bonesvoll P, Olsen I. Influence of teeth, plaque and dentures on the retention of chlorhexidine in the human oral cavity. J Clin Periodontol 1974; 1: 214-21.
30. Seymour RA, Meechan JG, Yates MS. Pharmacological control of dental caries and periodontal disease. In: Seymour RA, Meechan JG, Yates MS, eds. Pharmacology and dental therapeutics. Oxford: Oxford University Press, 1999; 179-96.
31. Vaahtoniemi LH. Surface ultrastructure of intact and in situ chlorhexidine-treated human buccal cells. A method for scanning electron microscopy. Acta Odontol Scand 1997; 55: 277-81.
32. Patel M, Shackleton JA, Coogan MM, Galpin J. Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatment-naive HIV-infected patients. AIDS Patient Care STDS 2008; 22: 613-8.
33. Addy M, Moran J, Davis RM, et al. The effect of single morning and evening rinses of chlorhexidine on the development of tooth staining and plaque accumulation. A blind crossover trial. J Clin Periodontol 1982; 9: 134-40.
34. Revankar SG, Kirkpatrick WR, McAtee RK, et al. A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance. Am J Med 1998; 105: 7-11.
35. Patton LL, Bonito AJ, Shugars DA. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 170-9.